Andrew Nava's  Instablog

Andrew Nava
Send Message
Andrew Nava LLC is a healthcare focused consulting and investment firm. Prior to launching Andrew Nava LLC, I was a venture analyst, buy-side analyst, and most recently, the Director of Research at Actin Biomed, a New York-based healthcare investment firm where I was responsible for the medical,... More
My company:
Andrew Nava, LLC
  • AVI BioPharma - An Active Second Half 0 comments
    Jul 1, 2010 6:10 PM | about stocks: SRPT

    AVI BioPharma (AVII) has several pending catalysts in 2H10, most of which could have a significant positive impact on the company's share price.  What can we expect from AVII?

    • AVI-4658 Data: Investors are awaiting key clinical data from the company's UK trial in Duchenne's muscular dystrophy.  Biopsy data released June 2nd on three patients, one each in the 2.0, 10 and 20 mg/kg cohorts, showed a 21%, 15%, and 55% increase in new dystrophin-positive muscle fibers, respectively.  The next catalyst is expected sometime in 3Q10.
    • AVI-4658 IND: Investors are also awaiting a potential clinical hold lift of the company's US IND.  Based on a 30-day FDA response time, the lift could come at anytime.
    • Biodefense award: AVII has submitted two Requests for Proposal (NYSE:RFP) for the DOD’s Ebola (AVI-6002) and Marburg (AVI-6003) development programs.  A decision could come as early as 2H10.
    To learn more about our research, or to become a client and receive our full report on AVII, please visit

    Andrew Nava LLC provides institutional and retail healthcare investors with buy-side equity research tools that focus on value-driven investing, profitable trading ideas and clinical, commercial, and regulatory catalysts. Our research is supported by our database of clinical trial data and upcoming company milestones, and by consulting with KOL's, industry professionals, analysts, and company management.

    Disclosure: No positions
    Stocks: SRPT
Back To Andrew Nava's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.